ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
1.110
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM
1.090
-0.020 (-1.80%)
After-hours: Jun 27, 2025, 7:56 PM EDT
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $50.80 million as of June 27, 2025. Its market cap has increased by 85.40% in one year.
Market Cap
50.80M
Enterprise Value
50.81M
1-Year Change
85.40%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $50.80M, a decrease of -79.73%. That is a compound annual growth rate of -29.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 36.50M | 225.89% |
| Dec 31, 2024 | 11.20M | -73.83% |
| Dec 29, 2023 | 42.80M | -67.05% |
| Dec 30, 2022 | 129.90M | 25.14% |
| Dec 31, 2021 | 103.80M | -58.58% |
| Dec 31, 2020 | 250.60M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.08B |
| Johnson & Johnson | 366.93B |
| AbbVie | 330.46B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.70B |
| Abbott Laboratories | 232.56B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |